Perceval Sondag currently serves as the Head of Nonclinical Biostatistics at Sanofi and is a Board of Directors Member at BEBPA, both roles initiated in March 2025 and March 2024 respectively. Additionally, Perceval holds an adjunct professorship at Rutgers University and has been a Statistics Expert Committee Member and Bioassay Expert Panel Member at US Pharmacopeia since October 2017. From September 2021 to December 2024, Perceval worked as a Senior Director of Digital Transformation and Data Science at Novo Nordisk, and from August 2021 to June 2024, taught Business Analytics at Fairleigh Dickinson University. Previous positions include Director of Commercial Data Science & Innovation at Merck and Head of Statistical Services at PharmaLex. Perceval's educational background includes a PhD in Biomedical and Pharmaceutical Sciences from the University of Liège and multiple degrees in Statistics and Physical Therapy from Université catholique de Louvain.
This person is not in the org chart
This person is not in any teams
This person is not in any offices